Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.verified

6875.TWO

Price:

$53

Market Cap:

$6.84B

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.

Industry

Biotechnology

IPO Date

2022-02-22

Stock Exchange

TWO

Ticker

6875.TWO

The PE Ratio as of December 2025 (TTM) for Pharmosa Biopharm Inc. (6875.TWO) is -28.80

According to Pharmosa Biopharm Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -28.80. This represents a change of 6.80% compared to the average of -0.42 of the last 4 quarters.

Pharmosa Biopharm Inc. (6875.TWO) Historical PE Ratio (quarterly & annually)

How has 6875.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Pharmosa Biopharm Inc. over the last ten years is 171.42. The current -28.80 PE Ratio has changed -1780.05% with respect to the historical average. Over the past ten years (40 quarters), 6875.TWO's PE Ratio was at its highest in in the December 2024 quarter at 48.71. The PE Ratio was at its lowest in in the March 2024 quarter at -48.28.

Quarterly (TTM)
Annual

Average

171.42

Median

-23.88

Minimum

-40.13

Maximum

1.17K

Pharmosa Biopharm Inc. (6875.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharmosa Biopharm Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 46.97%

Maximum Annual PE Ratio = 1.17K

Minimum Annual Increase = -5078.69%

Minimum Annual PE Ratio = -40.13

Quarterly (TTM)
Annual
YearPE RatioChange
2024-40.13-103.43%
20231.17K-5078.69%
2022-23.4846.97%
2021-15.97-34.23%
2020-24.29-33.43%

Pharmosa Biopharm Inc. (6875.TWO) Average PE Ratio

How has 6875.TWO PE Ratio performed in the past?

The current PE Ratio of Pharmosa Biopharm Inc. (6875.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

368.43

5-year avg

213.00

10-year avg

171.42

Pharmosa Biopharm Inc. (6875.TWO) PE Ratio vs. Peers

How is 6875.TWO’s PE Ratio compared to its peers?

Pharmosa Biopharm Inc.’s PE Ratio is greater than TaiGen Biopharmaceuticals Holdings Limited (-33.73), less than Mycenax Biotech Inc. (-13.57), less than OBI Pharma, Inc. (-2.87), greater than CHO Pharma, Inc. (-28.84), less than Sinphar Pharmaceutical Co.,Ltd. (17.78), greater than Adimmune Corporation (-36.04), greater than BioGend Therapeutics Co., Ltd. (-36.88), less than Panion & Bf Biotech Inc. (45.45), less than Savior Lifetec Corporation (13.33), less than Locus Cell Co., Ltd. (0),

Build a custom stock screener for Pharmosa Biopharm Inc. (6875.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmosa Biopharm Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmosa Biopharm Inc. (6875.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmosa Biopharm Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pharmosa Biopharm Inc.'s PE Ratio?

How is the PE Ratio calculated for Pharmosa Biopharm Inc. (6875.TWO)?

What is the highest PE Ratio for Pharmosa Biopharm Inc. (6875.TWO)?

What is the 3-year average PE Ratio for Pharmosa Biopharm Inc. (6875.TWO)?

What is the 5-year average PE Ratio for Pharmosa Biopharm Inc. (6875.TWO)?

How does the current PE Ratio for Pharmosa Biopharm Inc. (6875.TWO) compare to its historical average?